Trial · NCT00761007
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Response of Overall IBS Symptom Relief - 50% Rule | Ibodutant 10 mg | 79 | Participants | ||
| Response of Overall IBS Symptom Relief - 50% Rule | Ibodutant 30 mg | 61 | Participants | ||
| Response of Overall IBS Symptom Relief - 50% Rule | Ibodutant 60 mg | 61 | Participants | ||
| Response of Overall IBS Symptom Relief - 50% Rule | Placebo | 78 | Participants | ||
| Response of Overall IBS Symptom Relief - 75% Rule | Ibodutant 10 mg | 53 | Participants | ||
| Response of Overall IBS Symptom Relief - 75% Rule | Ibodutant 30 mg | 39 | Participants | ||
| Response of Overall IBS Symptom Relief - 75% Rule | Ibodutant 60 mg | 37 | Participants | ||
| Response of Overall IBS Symptom Relief - 75% Rule | Placebo | 48 | Participants | ||
| Response of Overall IBS Symptom Relief in the Subgroup of Patients With IBS-Diarrhea (IBS-D) and Pain at Baseline - 75% Rule | Ibodutant 10 mg | 31 | Participants | ||
| Response of Overall IBS Symptom Relief in the Subgroup of Patients With IBS-Diarrhea (IBS-D) and Pain at Baseline - 75% Rule | Ibodutant 30 mg | 15 | Participants | ||
| Response of Overall IBS Symptom Relief in the Subgroup of Patients With IBS-Diarrhea (IBS-D) and Pain at Baseline - 75% Rule | Ibodutant 60 mg | 17 | Participants | ||
| Response of Overall IBS Symptom Relief in the Subgroup of Patients With IBS-Diarrhea (IBS-D) and Pain at Baseline - 75% Rule | Placebo | 19 | Participants | ||
| Response of Overall IBS Symptom Relief in the Subgroup of Patients With IBS With Diarrhea (IBS-D) - 75% Rule | Ibodutant 10 mg | 33 | Participants | ||
| Response of Overall IBS Symptom Relief in the Subgroup of Patients With IBS With Diarrhea (IBS-D) - 75% Rule | Ibodutant 30 mg | 17 | Participants | ||
| Response of Overall IBS Symptom Relief in the Subgroup of Patients With IBS With Diarrhea (IBS-D) - 75% Rule | Ibodutant 60 mg | 22 | Participants | ||
| Response of Overall IBS Symptom Relief in the Subgroup of Patients With IBS With Diarrhea (IBS-D) - 75% Rule | Placebo | 25 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00761007/results